X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes
File(s)mp2014193a.pdf (1.1 MB)
Published version
Author(s)
Type
Journal Article
Abstract
X-linked intellectual disability (XLID) is a clinically and genetically heterogeneous disorder. During the past two decades in excess of
100 X-chromosome ID genes have been identified. Yet, a large number of families mapping to the X-chromosome remained
unresolved suggesting that more XLID genes or loci are yet to be identified. Here, we have investigated 405 unresolved families
with XLID. We employed massively parallel sequencing of all X-chromosome exons in the index males. The majority of these males
were previously tested negative for copy number variations and for mutations in a subset of known XLID genes by Sanger
sequencing. In total, 745 X-chromosomal genes were screened. After stringent filtering, a total of 1297 non-recurrent exonic
variants remained for prioritization. Co-segregation analysis of potential clinically relevant changes revealed that 80 families (20%)
carried pathogenic variants in established XLID genes. In 19 families, we detected likely causative protein truncating and missense
variants in 7 novel and validated XLID genes (CLCN4, CNKSR2, FRMPD4, KLHL15, LAS1L, RLIM and USP27X) and potentially deleterious
variants in 2 novel candidate XLID genes (CDK16 and TAF1). We show that the CLCN4 and CNKSR2 variants impair protein functions
as indicated by electrophysiological studies and altered differentiation of cultured primary neurons from Clcn4− / − mice or after
mRNA knock-down. The newly identified and candidate XLID proteins belong to pathways and networks with established roles in
cognitive function and intellectual disability in particular. We suggest that systematic sequencing of all X-chromosomal genes in a
cohort of patients with genetic evidence for X-chromosome locus involvement may resolve up to 58% of Fragile X-negative cases.
100 X-chromosome ID genes have been identified. Yet, a large number of families mapping to the X-chromosome remained
unresolved suggesting that more XLID genes or loci are yet to be identified. Here, we have investigated 405 unresolved families
with XLID. We employed massively parallel sequencing of all X-chromosome exons in the index males. The majority of these males
were previously tested negative for copy number variations and for mutations in a subset of known XLID genes by Sanger
sequencing. In total, 745 X-chromosomal genes were screened. After stringent filtering, a total of 1297 non-recurrent exonic
variants remained for prioritization. Co-segregation analysis of potential clinically relevant changes revealed that 80 families (20%)
carried pathogenic variants in established XLID genes. In 19 families, we detected likely causative protein truncating and missense
variants in 7 novel and validated XLID genes (CLCN4, CNKSR2, FRMPD4, KLHL15, LAS1L, RLIM and USP27X) and potentially deleterious
variants in 2 novel candidate XLID genes (CDK16 and TAF1). We show that the CLCN4 and CNKSR2 variants impair protein functions
as indicated by electrophysiological studies and altered differentiation of cultured primary neurons from Clcn4− / − mice or after
mRNA knock-down. The newly identified and candidate XLID proteins belong to pathways and networks with established roles in
cognitive function and intellectual disability in particular. We suggest that systematic sequencing of all X-chromosomal genes in a
cohort of patients with genetic evidence for X-chromosome locus involvement may resolve up to 58% of Fragile X-negative cases.
Date Issued
2015-02-03
Date Acceptance
2014-12-08
Citation
Molecular Psychiatry, 2015, 21 (1), pp.133-148
ISSN
1476-5578
Publisher
Nature Publishing Group
Start Page
133
End Page
148
Journal / Book Title
Molecular Psychiatry
Volume
21
Issue
1
Copyright Statement
This work is licensed under a Creative Commons AttributionNonCommercial-NoDerivs
4.0 International License. The images or
other third party material in this article are included in the article’s Creative Commons
license, unless indicated otherwise in the credit line; if the material is not included under
the Creative Commons license, users will need to obtain permission from the license
holder to reproduce the material. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-nd/4.0/
4.0 International License. The images or
other third party material in this article are included in the article’s Creative Commons
license, unless indicated otherwise in the credit line; if the material is not included under
the Creative Commons license, users will need to obtain permission from the license
holder to reproduce the material. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-nd/4.0/
Subjects
Science & Technology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
Neurosciences
Psychiatry
Neurosciences & Neurology
LINKED MENTAL-RETARDATION
AUTISM SPECTRUM DISORDERS
DE-NOVO MUTATIONS
HOMEODOMAIN TRANSCRIPTION FACTORS
LYSOSOMAL STORAGE DISEASE
MARTIN-PROBST SYNDROME
CHLORIDE CHANNEL
RIBOSOME BIOGENESIS
NEURITE OUTGROWTH
SPINE MORPHOGENESIS
Publication Status
Published